Insilico inks $66m collab to develop NLRP3 inhibitor for Parkinson\u2019s<\/h1>\n

AI-discovered drug displays anti-inflammatory activity in multiple CNS disease models and consistent blood\u2013brain barrier penetration.<\/strong><\/h2>\n

<\/div>\n

This week, AI-native drug discovery leader\u00a0Insilico Medicine<\/a>\u00a0announced its latest partnership, a co-development and licensing deal with Chinese biotech Hygtia Therapeutics to advance a brain-penetrant NLRP3 inhibitor aimed at treating central nervous system disorders. The companies will split worldwide rights to the asset equally, with Insilico eligible to receive up to $66 million in upfront and milestone-based payments, including a $10 million upfront payment.<\/p>\n

 <\/p>\n

https:\/\/longevity.technology\/news\/insilico-inks-66m-collab-to-develop-nlrp3-inhibitor-for-parkinsons\/<\/p>\n","protected":false},"excerpt":{"rendered":"

Insilico inks $66m collab to develop NLRP3 inhibitor for Parkinson\u2019s AI-discovered drug displays anti-inflammatory activity in multiple CNS disease models and consistent blood\u2013brain barrier penetration. This week, AI-native drug discovery leader\u00a0Insilico Medicine\u00a0announced its latest partnership, a co-development and licensing deal with Chinese biotech Hygtia Therapeutics to advance a brain-penetrant NLRP3 inhibitor aimed at treating central […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[56],"tags":[],"_links":{"self":[{"href":"https:\/\/jonathandespres.com\/cryonicsrevival\/wp-json\/wp\/v2\/posts\/2278"}],"collection":[{"href":"https:\/\/jonathandespres.com\/cryonicsrevival\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jonathandespres.com\/cryonicsrevival\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jonathandespres.com\/cryonicsrevival\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jonathandespres.com\/cryonicsrevival\/wp-json\/wp\/v2\/comments?post=2278"}],"version-history":[{"count":1,"href":"https:\/\/jonathandespres.com\/cryonicsrevival\/wp-json\/wp\/v2\/posts\/2278\/revisions"}],"predecessor-version":[{"id":2279,"href":"https:\/\/jonathandespres.com\/cryonicsrevival\/wp-json\/wp\/v2\/posts\/2278\/revisions\/2279"}],"wp:attachment":[{"href":"https:\/\/jonathandespres.com\/cryonicsrevival\/wp-json\/wp\/v2\/media?parent=2278"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jonathandespres.com\/cryonicsrevival\/wp-json\/wp\/v2\/categories?post=2278"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jonathandespres.com\/cryonicsrevival\/wp-json\/wp\/v2\/tags?post=2278"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}